Contributors
| April 1, 2013
Meet some of the people featured in the April 2013 issue of The Scientist.
| April 1, 2013
Meet some of the people featured in the April 2013 issue of The Scientist.
A decade into the age of genomics, science is generating a flood of data that will help in the quest to eradicate the disease.
The regulatory body that licenses drugs for use in the European Union is devising a policy that will require the publication of some clinical trial data.
Newly constructed ramps will expand the habitat available to a colony of water voles in London, and similar ramps elsewhere could encourage isolated populations to mix.
Tailoring ethical oversight to participant-led research
Native Australian frog tadpoles outcompete the tadpoles of the invasive cane toad, suggesting the native frogs could form part of a suburban control program.
Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?